Utilization of Molecular Quick Test as an Effort to Accelerate Case Findings of Multi Drug Resistant Tuberculosis in South Sulawesi Province

Abstract

The discovery of TB and MDR TB cases increases every year along with the addition of TCM machines, which currently number 46 machines and have spread across 24 districts/cities in the roadmap towards TB elimination in 2030. This study aims to determine the effectiveness of the use of Molecular Rapid Tests to accelerate the diagnosis of TB and MDR TB in South Sulawesi and to evaluate the utilization of TCM examinations for examination of TB and MDR TB during the Covid 19 pandemic. The method used in collecting TB and MDR TB data is to compile secondary data from several data sources, namely eTB Manager, TCM monthly reports, SITT and SITB. The data that has been collected will be processed and analyzed descriptively and presented in the form of tables and trend charts for 3 years. The number of case discoveries between 2018 and 2019 showed an increase in cases as more suspects were referred for TCM examination. In 2020 the discovery of TB cases has decreased, namely TB RO cases as many as 483 and TB SO cases as many as 7,736 cases. The decline in cases in 2020 was due to the Covid 19 pandemic where many suspects did not want to visit health facilities. The addition of the number of TCM can increase the case finding of TB SO and TB RO which is accompanied by strengthening the specimen referral network system, especially in areas with difficult transportation or remote areas so that the diagnosis of TB, especially TB with Rifampicin resistance can be found early.\n\nKeywords: Molecular Quick Test, Case Findings of Multi-Drug Resistant Tuberculosis.